Stock
Ramsay Healthcare $57.49 as at 21/6/18
Event
Ramsay made a poor announcement this morning taking a non-cash write down on some UK assets, but more importantly, they amended their FY guidance down from earnings per share (eps) growth of 8-10% to now expecting growth of 7%. The prior guidance implied eps of $2.86 while market consensus was sitting just below that at $2.84. New guidance implies eps of $2.80 for FY 18, still reasonable growth, but clearly the 20+% levels of the past are now harder to come by.
